Melatonin in mitochondrial dysfunction and related disorders

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Srinivasan, Venkatramanujam ^a   Spence, D Warren ^b   Pandi Perumal, Seithikurippu R ^c   Brown, Gregory M ^d   Cardinali, Daniel P ^e,f  

^a Educational and Research Foundation   (India)

^b Somnogen Inc ^*  (Canada)

^c Somnogen Inc   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e PONTIFICIA UNIVERSIDAD CATÓLICA ARGENTINA   (Argentina)

^f UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACETYLSEROTONIN METHYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; AGOMELATINE; AMYLOID BETA PROTEIN[1-42]; ANTIOXIDANT; BETA SECRETASE INHIBITOR; FREE RADICAL; GAMMA SECRETASE INHIBITOR; GLUTATHIONE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; KYNURAMINE; MELATONIN; MELATONIN 1 RECEPTOR; N 1 ACETYL N 2 FORMYL 5 METHOXYKYNURAMINE; N ACETYL 5 METHOXYKYNURENAMINE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAMELTEON; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SCAVENGER; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN MITOCHONDRION; CELL MEMBRANE POTENTIAL; CELL PROTECTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; ENDOTOXEMIA; EXPERIMENTAL MODEL; FLUID RESUSCITATION; GLUTATHIONE METABOLISM; HEART INFARCTION; HEART PROTECTION; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; INSOMNIA; LIPID PEROXIDATION; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE; NEUROPATHOLOGY; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK;

EID: 79959229736     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/326320     Document Type: Review

References (202)

1. Beal M. F., Mitochondrial dysfunction in neurodegenerative diseases Biochimica et Biophysica Acta 1998 1366 1-2 211 223 (Pubitemid 28467033)
2. Beal M. F., Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease Parkinsonism and Related Disorders 2009 15 3 S189 S194
3. Wallace D. C., Fan W., The pathophysiology of mitochondrial disease as modeled in the mouse Genes and Development 2009 23 15 1714 1736
4. Wallace D. C., Mitochondrial diseases in man and mouse Science 1999 283 5407 1482 1488
5. Schon E. A., DiMauro S., Hirano M., Gilkerson R. W., Therapeutic prospects for mitochondrial disease Trends in Molecular Medicine 2010 16 6 268 276
6. DiMauro S., Schon E. A., Mitochondrial disorders in the nervous system Annual Review of Neuroscience 2008 31 91 123
7. DiMauro S., Schon E. A., Mitochondrial respiratory-chain diseases New England Journal of Medicine 2003 348 26 2656 2668 (Pubitemid 36741594)
8. Brealey D., Karyampudi S., Jacques T. S., Novelli M., Stidwill R., Taylor V., Smolenski R. T., Singer M., Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure American Journal of Physiology 2004 286 3 R491 R497
9. Rezin G. T., Amboni G., Zugno A. I., Quevedo J., Streck E. L., Mitochondrial dysfunction and psychiatric disorders Neurochemical Research 2009 34 6 1021 1029
10. Rollins B., Martin M. V., Sequeira P. A., Moon E. A., Morgan L. Z., Watson S. J., Schatzberg A., Akil H., Myers R. M., Jones E. G., Wallace D. C., Bunney W. E., Vawter M. P., Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder PLoS One 2009 4 3
11. Miquel J., Economos A. C., Fleming J., Johnson J. E., Mitochondrial role in cell aging Experimental Gerontology 1980 15 6 575 591 (Pubitemid 11243249)
12. Raha S., Robinson B. H., Mitochondria, oxygen free radicals, disease and ageing Trends in Biochemical Sciences 2000 25 10 502 508
13. Genova M. L., Pich M. M., Bernacchia A., Bianchi C., Biondi A., Bovina C., Falasca A. I., Formiggini G., Castelli G. P., Lenaz G., The mitochondrial production of reactive oxygen species in relation to aging and pathology Annals of the New York Academy of Sciences 2004 1011 86 100 (Pubitemid 38608395)
14. Martin M., Macias M., Escames G., Leon J., Acuna-Castroviejo D., Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress FASEB Journal 2000 14 12 1677 1679
15. Martn M., Macas M., Escames G., Reiter R. J., Agapito M. T., Ortiz G. G., Acua-Castroviejo D., Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo Journal of Pineal Research 2000 28 4 242 248 (Pubitemid 30255377)
16. Martn M., Macas M., Len J., Escames G., Khaldy H., Acua-Castroviejo D., Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria International Journal of Biochemistry and Cell Biology 2002 34 4 348 357 (Pubitemid 34164278)
17. Leon J., Acua-Castroviejo D., Sainz R. M., Mayo J. C., Tan D. X., Reiter R. J., Melatonin and mitochondrial function Life Sciences 2004 75 7 765 790 (Pubitemid 38737416)
18. Lpez A., Garca J. A., Escames G., Venegas C., Ortiz F., Lpez L. C., Acua-Castroviejo D., Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production Journal of Pineal Research 2009 46 2 188 198
19. Castroviejo D. A., Lpez L. C., Escames G., Lpez A., Garca J. A., Reiter R. J., Melatonin-mitochondria interplay in health and disease Current Topics in Medicinal Chemistry 2011 11 2 221 240
20. Anderson S., Bankier A. T., Barrell B. G., Sequence and organization of the human mitochondrial genome Nature 1981 290 5806 457 465 (Pubitemid 11159074)
21. Berg O. G., Kurland C. G., Why mitochondrial genes are most often found in nuclei Molecular Biology and Evolution 2000 17 6 951 961 (Pubitemid 30346555)
22. Schatz G., Mitochondria: beyond oxidative phosphorylation Biochimica et Biophysica Acta 1995 1271 1 123 126
23. Lenaz G., Genova M. L., Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject Antioxidants and Redox Signaling 2010 12 8 961 1008
24. Lee I., Bender E., Arnold S., Kadenbach B., New control of mitochondrial membrane potential and ROS formationa hypothesis Biological Chemistry 2001 382 12 1629 1636 (Pubitemid 34100594)
25. Genova M. L., Ventura B., Giuliano G., Bovina C., Formiggini G., Parenti Castelli G., Lenaz G., The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2 FEBS Letters 2001 505 3 364 368 (Pubitemid 32905478)
26. Ghafourifar P., Richter C., Nitric oxide synthase activity in mitochondria FEBS Letters 1997 418 3 291 296 (Pubitemid 27515942)
27. Mander P., Brown G. C., Nitric oxide, hypoxia and brain inflammation Biochemical Society Transactions 2004 32 6 1068 1069 (Pubitemid 39655546)
28. Esposito E., Cuzzocrea S., Antiinflammatory activity of melatonin in central nervous system Current Neuropharmacology 2010 8 3 228 242
29. Murray J., Taylor S. W., Zhang B., Ghosh S. S., Capaldi R. A., Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry Journal of Biological Chemistry 2003 278 39 37223 37230 (Pubitemid 37175238)
30. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B. A., Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives Journal of Biological Chemistry 1994 269 42 26066 26075
31. Stadtman E. R., Levine R. L., Free radical-mediated oxidation of free amino acids and amino acid residues in proteins Amino Acids 2003 25 3-4 207 218 (Pubitemid 38043943)
32. Levine R. L., Stadtman E. R., Oxidative modification of proteins during aging Experimental Gerontology 2001 36 9 1495 1502 (Pubitemid 32768727)
33. Kim J. S., He L., Lemasters J. J., Mitochondrial permeability transition: a common pathway to necrosis and apoptosis Biochemical and Biophysical Research Communications 2003 304 3 463 470 (Pubitemid 36506518)
34. Szalai G., Krishnamurthy R., Hajnczky G., Apoptosis driven by IP-linked mitochondrial calcium signals EMBO Journal 1999 18 22 6349 6361 (Pubitemid 29533239)
35. Lemasters J. J., Theruvath T. P., Zhong Z., Nieminen A. L., Mitochondrial calcium and the permeability transition in cell death Biochimica et Biophysica Acta 2009 1787 11 1395 1401
36. Nicholls D. G., Budd S. L., Mitochondria and neuronal survival Physiological Reviews 2000 80 1 315 360 (Pubitemid 30060567)
37. Drge W., Free radicals in the physiological control of cell function Physiological Reviews 2002 82 1 47 95
38. Liochev S. I., Fridovich I., Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase Free Radical Biology and Medicine 2010 48 12 1565 1569
39. Chance B., Sies H., Boveris A., Hydroperoxide metabolism in mammalian organs Physiological Reviews 1979 59 3 527 605 (Pubitemid 9236599)
40. Urata Y., Honma S., Goto S., Todoroki S., Iida T., Cho S., Honma K., Kondo T., Melatonin induces -glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells Free Radical Biology and Medicine 1999 27 7-8 838 847 (Pubitemid 29454587)
41. Antoln I., Rodriguez C., Sinz R. M., Mayo J. C., Ura H., Kotler M. L., Rodrguez-Colunga M. J., Tolivia D., Menndez-Pelez A., Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes FASEB Journal 1996 10 8 882 890 (Pubitemid 26184166)
42. Pablos M. I., Reiter R. J., Ortiz G. G., Guerrero J. M., Agapito M. T., Chuang J. I., Sewerynek E., Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light Neurochemistry International 1998 32 1 69 75 (Pubitemid 28020239)
43. Reiter R. J., Tan D. X., Osuna C., Gitto E., Actions of melatonin in the reduction of oxidative stress: a review Journal of Biomedical Science 2000 7 6 444 458
44. Rodriguez C., Mayo J. C., Sainz R. M., Antoln I., Herrera F., Martn V., Reiter R. J., Regulation of antioxidant enzymes: a significant role for melatonin Journal of Pineal Research 2004 36 1 1 9 (Pubitemid 38130283)
45. Jimnez-Ortega V., Cano P., Cardinali D. P., Esquifino A. I., 24-hour variation in gene expression of redox pathway enzymes in rat hypothalamus: effect of melatonin treatment Redox Report 2009 14 3 132 138
46. Hara M., Yoshida M., Nishijima H., Yokosuka M., Iigo M., Ohtani-Kaneko R., Shimada A., Hasegawa T., Akama Y., Hirata K., Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats Journal of Pineal Research 2001 30 3 129 138 (Pubitemid 32245283)
47. Escames G., Lpez A., Garca J. A., Garca L., Acua-Castroviejo D., Garca J. J., Lpez L. C., The role of mitochondria in brain aging and the effects of melatonin Current Neuropharmacology 2010 8 3 182 193
48. Lerner A. B., Case J. D., Takahashi Y., Lee T. H., Mori W., Isolation of melatonin, the pineal gland factor that lightens melanocytes Journal of the American Chemical Society 1958 80 10 2587
49. Carrillo-Vico A., Calvo J. R., Abreu P., Lardone P. J., Garca-Maurio S., Reiter R. J., Guerrero J. M., Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance The FASEB Journal 2004 18 3 537 539
50. Slominski A., Fischer T. W., Zmijewski M. A., Wortsman J., Semak I., Zbytek B., Slominski R. M., Tobin D. J., On the role of melatonin in skin physiology and pathology Endocrine 2005 27 2 137 147 (Pubitemid 41558446)
51. Bubenik G. A., Gastrointestinal melatonin: localization, function, and clinical relevance Digestive Diseases and Sciences 2002 47 10 2336 2348 (Pubitemid 35205309)
52. Jimenez-Jorge S., Jimenez-Caliani A. J., Guerrero J. M., Naranjo M. C., Lardone P. J., Carrillo-Vico A., Osuna C., Molinero P., Melatonin synthesis and melatonin-membrane receptor (MT1) expression during rat thymus development: role of the pineal gland Journal of Pineal Research 2005 39 1 77 83 (Pubitemid 40966466)
53. Rosenstein R. E., Pandi-Perumal S. R., Srinivasan V., Spence D. W., Brown G. M., Cardinali D. P., Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis Journal of Pineal Research 2010 49 1 1 13
54. Conti A., Conconi S., Hertens E., Skwarlo-Sonta K., Markowska M., Maestroni G. J. M., Evidence for melatonin synthesis in mouse and human bone marrow cells Journal of Pineal Research 2000 28 4 193 202 (Pubitemid 30255371)
55. Liu T., Borjigin J., N-acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night Journal of Pineal Research 2005 39 1 91 96 (Pubitemid 40966468)
56. Ackermann K., Stehle J. H., Melatonin synthesis in the human pineal gland: advantages, implications, and difficulties Chronobiology International 2006 23 1-2 369 379 (Pubitemid 43739048)
57. Tricoire H., Mller M., Chemineau P., Malpaux B., Origin of cerebrospinal fluid melatonin and possible function in the integration of photoperiod Reproduction Supplement 2003 61 311 321
58. Leston J., Harth C., Brun J., Mottolese C., Mertens P., Sindou M., Claustrat B., Melatonin is released in the third ventricle in humans. A study in movement disorders Neuroscience Letters 2010 469 3 294 297
59. Tan D.-X., Manchester L. C., Sanchez-Barcelo E., Mediavilla M. D., Reiter R. J., Significance of high levels of endogenous melatonin in mammalian cerebrospinal fluid and in the central nervous system Current Neuropharmacology 2010 8 3 162 167
60. Cardinali D. P., Lynch H. J., Wurtman R. J., Binding of melatonin to human and rat plasma proteins Endocrinology 1972 91 5 1213 1218
61. Gilad E., Zisapel N., High-affinity binding of melatonin to hemoglobin Biochemical and Molecular Medicine 1995 56 2 115 120 (Pubitemid 26029433)
62. Tan D. X., Manchester L. C., Reiter R. J., Plummer B. F., Hardies L. J., Weintraub S. T., Vijayalaxmi., Shepherd A. M. M., A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation Biochemical and Biophysical Research Communications 1998 253 3 614 620 (Pubitemid 29039192)
63. Hirata F., Hayaishi O., Tokuyama T., Senoh S., In vitro and in vitro formation of two new metabolites of melatonin Journal of Biological Chemistry 1974 249 4 1311 1313
64. Tan D. X., Manchester L. C., Burkhardt S., Sainz R. M., Mayo J. C., Kohen R., Shohami E., Huo Y. S., Hardeland R., Reiter R. J., N 1 -acetyl- N 2 -formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant The FASEB Journal 2001 15 12 2294 2296
65. Hardeland R., Tan D. X., Reiter R. J., Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines Journal of Pineal Research 2009 47 2 109 126
66. Reiter R. J., The pineal and its hormones in the control of reproduction in mammals Endocrine Reviews 1980 1 2 109 131
67. Srinivasan V., Spence W. D., Pandi-Perumal S. R., Zakharia R., Bhatnagar K. P., Brzezinski A., Melatonin and human reproduction: shedding light on the darkness hormone Gynecological Endocrinology 2009 25 12 779 785
68. Wurtman R. J., Zhdanova I., Improvement of sleep quality by melatonin Lancet 1995 346 8988 1491
69. Guerrero J. M., Reiter R. J., Melatonin-immune system relationships Current topics in medicinal chemistry 2002 2 2 167 179
70. Srinivasan V., Maestroni G. J. M., Cardinali D. P., Esquifino A. I., Pandi Perumal S. R., Miller S. C., Melatonin, immune function and aging Immunity and Ageing 2005 2, article no. 17
71. Armstrong S. M., Melatonin and circadian control in mammals Experientia 1989 45 10 932 938 (Pubitemid 19254805)
72. Deacon S., Arendt J., Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans Brain Research 1995 688 1-2 77 85
73. Rajaratnam S. M. W., Middleton B., Stone B. M., Arendt J., Dijk D. J., Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans Journal of Physiology 2004 561 1 339 351 (Pubitemid 39555458)
74. Arendt J., Skene D. J., Melatonin as a chronobiotic Sleep Medicine Reviews 2005 9 1 25 39 (Pubitemid 40092916)
75. Blask D. E., Dauchy R. T., Sauer L. A., Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal Endocrine 2005 27 2 179 188 (Pubitemid 41558450)
76. Srinivasan V., Spence D. W., Pandi-Perumal S. R., Trakht I., Cardinali D. P., Therapeutic actions of melatonin in cancer: possible mechanisms Integrative Cancer Therapies 2008 7 3 189 203
77. Srinivasan V., Pandi-Perumal S. R., Spence D. W., Moscovitch A., Trakht I., Brown G. M., Cardinali D. P., Potential use of melatonergic drugs in analgesia: mechanisms of action Brain Research Bulletin 2010 81 4-5 362 371
78. Cardinali D. P., Furio A. M., Reyes M. P., Brusco L. I., The use of chronobiotics in the resynchronization of the sleep-wake cycle Cancer Causes and Control 2006 17 4 601 609
79. Dawson D., Armstrong S. M., Chronobioticsdrugs that shift rhythms Pharmacology and Therapeutics 1996 69 1 15 36
80. Pvet P., Bothorel B., Slotten H., Saboureau M., The chronobiotic properties of melatonin Cell and Tissue Research 2002 309 1 183 191 (Pubitemid 34744040)
81. Reppert S. M., Weaver D. R., Ebisawa T., Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses Neuron 1994 13 5 1177 1185 (Pubitemid 24372135)
82. Reppert S. M., Godson C., Mahle C. D., Weaver D. R., Slaugenhaupt S. A., Gusella J. F., Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor Proceedings of the National Academy of Sciences of the United States of America 1995 92 19 8734 8738
83. Dubocovich M. L., Delagrange P., Krause D. N., Sugden D., Cardinali D. P., Olcese J., International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors Pharmacological Reviews 2010 62 3 343 380
84. Nosjean O., Ferro M., Cog F., Beauverger P., Henlin J. M., Lefoulon F., Fauche J. L., Delagrange P., Canet E., Boutin J. A., Identification of the melatonin-binding site MT as the quinone reductase 2 Journal of Biological Chemistry 2000 275 40 31311 31317
85. Wiesenberg I., Missbach M., Kahlen J. P., Schrader M., Carlberg C., Transcriptional activation of the nuclear receptor RZR by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand Nucleic Acids Research 1995 23 3 327 333
86. Carlberg C., Gene regulation by melatonin Annals of the New York Academy of Sciences 2000 917 387 396
87. Toms-Zapico C., Coto-Montes A., A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes Journal of Pineal Research 2005 39 2 99 104 (Pubitemid 41140746)
88. Menendez-Pelaez A., Poeggeler B., Reiter R. J., Barlow-Walden L., Pablos M. I., Tan D. X., Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence Journal of Cellular Biochemistry 1993 53 4 373 382 (Pubitemid 24043036)
89. Tan D. X., Poeggeler B., Reiter R. J., Chen L. D., Chen S., Manchester L. C., Barlow-Walden L. R., The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo Cancer Letters 1993 70 1-2 65 71 (Pubitemid 23219861)
90. Hardeland R., Reiter R. J., Poeggeler B., Tan D. X., The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances Neuroscience and Biobehavioral Reviews 1993 17 3 347 357 (Pubitemid 23306320)
91. Poeggeler B., Thuermann S., Dose A., Schoenke M., Burkhardt S., Hardeland R., Melatonin's unique radical scavenging propertiesroles of its functional substituents as revealed by a comparison with its structural analogs Journal of Pineal Research 2002 33 1 20 30 (Pubitemid 34833071)
92. Hardeland R., Poeggeler B., Niebergall R., Zelosko V., Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage Journal of Pineal Research 2003 34 1 17 25 (Pubitemid 36140353)
93. Hardeland R., Coto-Montes A., New vistas on oxidative damage and aging The Open Biology Journal 2010 3 39 52
94. Rosen J., Than NI. N., Koch D., Poeggeler B., Laatsch H., Hardeland R., Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones Journal of Pineal Research 2006 41 4 374 381 (Pubitemid 44498224)
95. Tan D., Reiter R. J., Chen L., Poeggeler B., Manchester L. C., Barlow-Walden L. R., Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole Carcinogenesis 1994 15 2 215 218 (Pubitemid 24121651)
96. Reiter R. J., Tan D. X., Mayo J. C., Sainz R. M., Leon J., Czarnocki Z., Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans Acta Biochimica Polonica 2003 50 4 1129 1146 (Pubitemid 38608841)
97. Hardeland R., Poeggeler B., Melatonin beyond its classical functions The Open Physiology Journal 2008 1 1 23
98. Hardeland R., Coto-Montes A., Poeggeler B., Circadian rhythms, oxidative stress, and antioxidative defense mechanisms Chronobiology International 2003 20 6 921 962 (Pubitemid 37517510)
99. Hardeland R., Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance Endocrine 2005 27 2 119 130 (Pubitemid 41558444)
100. Hardeland R., Melatonin: signaling mechanisms of a pleiotropic agent BioFactors 2009 35 2 183 192
101. Collins-Underwood J. R., Zhao W., Sharpe J. G., Robbins M. E., NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells Free Radical Biology and Medicine 2008 45 6 929 938
102. McCann S. K., Dusting G. J., Roulston C. L., Early increase of Nox4 NADPH oxidase and superoxide generation following endothelin-1-induced stroke in conscious rats Journal of Neuroscience Research 2008 86 11 2524 2534
103. Chen C. L., Chen J., Rawale S., Varadharaj S., Kaumaya P. P. T., Zweier J. L., Chen Y. R., Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium Journal of Biological Chemistry 2008 283 41 27991 28003
104. Schiavone S., Sorce S., Dubois-Dauphin M., Jaquet V., Colaianna M., Zotti M., Cuomo V., Trabace L., Krause K. H., Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats Biological Psychiatry 2009 66 4 384 392
105. Zhou J., Zhang S., Zhao X., Wei T., Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-β Journal of Pineal Research 2008 45 2 157 165
106. Aoshima H., Kadoya K., Taniguchi H., Satoh T., Hatanaka H., Generation of free radicals during the death of Saccharomyces cerevisiae caused by lipid hydroperoxide Bioscience, Biotechnology and Biochemistry 1999 63 6 1025 1031 (Pubitemid 129562724)
107. Okatani Y., Wakatsuki A., Reiter R. J., Miyahara Y., Acutely administered melatonin restores hepatic mitochondrial physiology in old mice International Journal of Biochemistry and Cell Biology 2003 35 3 367 375 (Pubitemid 36084459)
108. Reyes-Toso C. F., Rebagliati I. R., Ricci C. R., Linares L. M., Albornoz L. E., Cardinali D. P., Zaninovich A., Effect of melatonin treatment on oxygen consumption by rat liver mitochondria Amino Acids 2006 31 3 299 302 (Pubitemid 44537055)
109. Hibaoui Y., Roulet E., Ruegg U. T., Melatonin prevents oxidative stress-mediated mitochondrial permeability transition and death in skeletal muscle cells Journal of Pineal Research 2009 47 3 238 252
110. Paradies G., Petrosillo G., Paradies V., Reiter R. J., Ruggiero F. M., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease Journal of Pineal Research 2010 48 4 297 310
111. Petrosillo G., Fattoretti P., Matera M., Ruggiero F. M., Bertoni-Freddari C., Paradies G., Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection Rejuvenation Research 2008 11 5 935 943
112. Linnane A. W., Marzuki S., Ozawa T., Tanaka M., Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases Lancet 1989 1 8639 642 645 (Pubitemid 19078788)
113. Yen T. C., Chen Y. S., King K. L., Yeh S. H., Wei Y. H., Liver mitochondrial respiratory functions decline with age Biochemical and Biophysical Research Communications 1989 165 3 994 1003
114. Cooper J. M., Mann V. M., Schapira A. H. V., Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing Journal of the Neurological Sciences 1992 113 1 91 98
115. Wei Y. H., Wu S. B., Ma Y. S., Lee H. C., Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging Chang Gung Medical Journal 2009 32 2 113 132
116. Sohal R. S., Sohal B. H., Hydrogen peroxide release by mitochondria increases during aging Mechanisms of Ageing and Development 1991 57 2 187 202
117. Perez-Campo R., Lpez-Torres M., Cadenas S., Rojas C., Barja G., The rate of free radical production as a determinant of the rate of aging: Evidence from the comparative approach Journal of Comparative Physiology B 1998 168 3 149 158 (Pubitemid 28202995)
118. Pesce V., Cormio A., Fracasso F., Vecchiet J., Felzani G., Lezza A. M. S., Cantatore P., Gadaleta M. N., Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle Free Radical Biology and Medicine 2001 30 11 1223 1233 (Pubitemid 32463933)
119. Mather M., Rottenberg H., Aging enhances the activation of the permeability transition pore in mitochondria Biochemical and Biophysical Research Communications 2000 273 2 603 608 (Pubitemid 30599032)
120. Takeda T., Senescence-accelerated mouse (SAM): a biogerontological resource in aging research Neurobiology of Aging 1999 20 2 105 110 (Pubitemid 29488720)
121. Hosokawa M., A higher oxidative status accelerates senescence and aggravates age-dependent disorders in SAMP strains of mice Mechanisms of Ageing and Development 2002 123 12 1553 1561 (Pubitemid 35449219)
122. Okatani Y., Wakatsuki A., Reiter R. J., Miyahara Y., Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin Journal of Pineal Research 2002 33 3 127 133
123. Okatani Y., Wakatsuki A., Reiter R. J., Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice Journal of Pineal Research 2002 32 3 143 148 (Pubitemid 34309880)
124. Okatani Y., Wakatsuki A., Reiter R. J., Miyahara Y., Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse Neurobiology of Aging 2002 23 4 639 644 (Pubitemid 34493894)
125. Rebrin I., Zicker S., Wedekind K. J., Paetau-Robinson I., Packer L., Sohal R. S., Effect of antioxidant-enriched diets on glutathione redox status in tissue homogenates and mitochondria of the senescence-accelerated mouse Free Radical Biology and Medicine 2005 39 4 549 557 (Pubitemid 41021653)
126. Rodriguez M. I., Escames G., Lpez L. C., Garca J. A., Ortiz F., Lpez A., Acua-Castroviejo D., Melatonin administration prevents cardiac and diaphragmatic mitochondrial oxidative damage in senescence-accelerated mice Journal of Endocrinology 2007 194 3 637 643 (Pubitemid 47471232)
127. Rodrguez M. I., Escames G., Lpez L. C., Lpez A., Garca J. A., Ortiz F., Snchez V., Romeu M., Acua-Castroviejo D., Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice Experimental Gerontology 2008 43 8 749 756
128. Navarro A., Boveris A., Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease Frontiers in Aging Neuroscience 2010 2, article 34
129. Carretero M., Escames G., Lpez L. C., Venegas C., Dayoub J. C., Garca L., Acua-Castroviejo D., Long-term melatonin administration protects brain mitochondria from aging Journal of Pineal Research 2009 47 2 192 200
130. Navarro A., Boveris A., The mitochondrial energy transduction system and the aging process American Journal of Physiology 2007 292 2 C670 C686
131. Fosslien E., Mitochondrial medicinemolecular pathology of defective oxidative phosphorylation Annals of Clinical and Laboratory Science 2001 31 1 25 67 (Pubitemid 32097212)
132. Mukherjee D., Roy S. G., Bandyopadhyay A., Chattopadhyay A., Basu A., Mitra E., Ghosh A. K., Reiter R. J., Bandyopadhyay D., Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms Journal of Pineal Research 2010 48 3 251 262
133. Reiter R. J., Tan D. X., Fuentes-Broto L., Melatonin salvages neural tissue from ischemia/reperfusion injury The Open Neuroendocrinology Journal 2010 3 112 120
134. Ambrosio G., Zweier J. L., Flaherty J. T., The relationship between oxygen radical generation and impairment of myocardial energy metabolism following post-ischemic reperfusion Journal of Molecular and Cellular Cardiology 1991 23 12 1359 1374
135. Vanden Hoek T. L., Shao Z., Li C., Zak R., Schumacker P. T., Becker L. B., Reperfusion injury in cardiac myocytes after simulated ischemia American Journal of Physiology 1996 270 4 H1334 H1341
136. Halestrap A. P., Pasdois P., The role of the mitochondrial permeability transition pore in heart disease Biochimica et Biophysica Acta 2009 1787 11 1402 1415
137. Tan D. X., Manchester L. C., Reiter R. J., Qi W., Kim S. J., El-Sokkary G. H., Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin Journal of Pineal Research 1998 25 3 184 191 (Pubitemid 28430599)
138. Kaneko S., Okumura K., Numaguchi Y., Matsui H., Murase K., Mokuno S., Morishima I., Hira K., Toki Y., Ito T., Hayakawa T., Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury Life Sciences 2000 67 2 101 112 (Pubitemid 30414477)
139. Salie R., Harper I., Cillie C., Genade S., Huisamen B., Moolman J., Lochner A., Melatonin protects against ischaemic-reperfusion myocardial damage Journal of Molecular and Cellular Cardiology 2001 33 2 343 357 (Pubitemid 32537932)
140. Andrabi S. A., Sayeed I., Siemen D., Wolf G., Horn T. F., Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin The FASEB Journal 2004 18 7 869 871
141. Luchetti F., Canonico B., Mannello F., Masoni C., D'Emilio A., Battistelli M., Papa S., Falcieri E., Melatonin reduces early changes in intramitochondrial cardiolipin during apoptosis in U937 cell line Toxicology in Vitro 2007 21 2 293 301 (Pubitemid 46205074)
142. Sahna E., Parlakpinar H., Turkoz Y., Acet A., Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes Physiological Research 2005 54 5 491 495 (Pubitemid 41578671)
143. Petrosillo G., Moro N., Ruggiero F. M., Paradies G., Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release Free Radical Biology and Medicine 2009 47 7 969 974
144. Castagnino H. E., Lago N., Centrella J. M., Calligaris S. D., Faria S., Sarchi M. I., Cardinali D. P., Cytoprotection by melatonin and growth hormone in early rat myocardial infarction as revealed by Feulgen DNA staining Neuroendocrinology Letters 2002 23 5-6 391 395 (Pubitemid 36050014)
145. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N. A., Cooper C. E., Singer M., Association between mitochondrial dysfunction and severity and outcome of septic shock Lancet 2002 360 9328 219 223 (Pubitemid 34804650)
146. Escames G., Len J., Macas M., Khaldy H., Acua-Castroviejo D., Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats The FASEB Journal 2003 17 8 932 934
147. Srinivasan V., Pandi-Perumal S. R., Spence D. W., Kato H., Cardinali D. P., Melatonin in septic shock: some recent concepts Journal of Critical Care 2010 25 4 656.e1 656.e6
148. Escames G., Lpez L. C., Tapias V., Utrilla P., Reiter R. J., Hitos A. B., Len J., Rodrguez M. I., Acua-Castroviejo D., Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice Journal of Pineal Research 2006 40 1 71 78
149. Lpez L. C., Escames G., Tapias V., Utrilla P., Len J., Acua-Castroviejo D., Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin International Journal of Biochemistry and Cell Biology 2006 38 2 267 278 (Pubitemid 41619455)
150. Gibson G. E., Starkov A., Blass J. P., Ratan R. R., Beal M. F., Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases Biochimica et Biophysica Acta 2010 1802 1 122 134
151. Olanow C. W., An introduction to the free radical hypothesis in
152. Fahn S., Cohen G., The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Annals of Neurology 1992 32 6 804 812
153. Hattori N., Ikebe S., Tanaka M., Ozawa T., Mizuno Y., Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease Advances in neurology 1993 60 292 296
154. Gu M., Owen A. D., Toffa S. E. K., Cooper J. M., Dexter D. T., Jenner P., Marsden C. D., Schapira A. H. V., Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases Journal of the Neurological Sciences 1998 158 1 24 29 (Pubitemid 28277530)
155. Schober A., Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP Cell and Tissue Research 2004 318 1 215 224 (Pubitemid 39366054)
156. Terzioglu M., Galter D., Parkinson's disease: genetic versus toxin-induced rodent models FEBS Journal 2008 275 7 1384 1391 (Pubitemid 351388790)
157. Przedborski S., Tieu K., Perier C., Vila M., MPTP as a mitochondrial neurotoxic model of Parkinson's disease Journal of Bioenergetics and Biomembranes 2004 36 4 375 379 (Pubitemid 39619844)
158. Brown G. C., Borutaite V., Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols Biochimica et Biophysica Acta 2004 1658 1-2 44 49 (Pubitemid 39013232)
159. Muravchick S., Levy R. J., Clinical implications of mitochondrial dysfunction Anesthesiology 2006 105 4 819 837 (Pubitemid 44477329)
160. Absi E., Ayala A., Machado A., Parrado J., Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of Complex I of the mitochondrial respiratory chain Journal of Pineal Research 2000 29 1 40 47 (Pubitemid 30449700)
161. Tapias V., Escames G., Lpez L. C., Lpez A., Camacho E., Carrin M. D., Entrena A., Gallo M. A., Espinosa A., Acua-Castroviejo D., Melatonin and its brain metabolite N-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in Parkinsonian mice Journal of Neuroscience Research 2009 87 13 3002 3010
162. Dowling G. A., Mastick J., Colling E., Carter J. H., Singer C. M., Aminoff M. J., Melatonin for sleep disturbances in Parkinson's disease Sleep Medicine 2005 6 5 459 466 (Pubitemid 41245369)
163. Medeiros C. A. M., Carvalhedo De Bruin P. F., Lopes L. A., Magalhes M. C., De Lourdes Seabra M., Sales De Bruin V. M., Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: a randomized, double blind, placebo-controlled study Journal of Neurology 2007 254 4 459 464 (Pubitemid 46786720)
164. Kunz D., Bes F., Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations Neuropsychobiology 1997 36 4 211 214 (Pubitemid 27472520)
165. Kunz D., Bes F., Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation Movement Disorders 1999 14 3 507 511 (Pubitemid 30011666)
166. Takeuchi N., Uchimura N., Hashizume Y., Mukai M., Etoh Y., Yamamoto K., Kotorii T., Ohshima H., Ohshima M., Maeda H., Melatonin therapy for REM sleep behavior disorder Psychiatry and Clinical Neurosciences 2001 55 3 267 269 (Pubitemid 32578377)
167. Boeve B. F., Silber M. H., Ferman T. J., Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients Sleep Medicine 2003 4 4 281 284 (Pubitemid 36974807)
168. Anderson K. N., Shneerson J. M., Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam Journal of Clinical Sleep Medicine 2009 5 3 235 239
169. Aurora R. N., Zak R. S., Maganti R. K., Auerbach S. H., Casey K. R., Chowdhuri S., Karippot A., Ramar K., Kristo D. A., Morgenthaler T. I., Tracy S. L., Best practice guide for the treatment of REM sleep behavior disorder (RBD) Journal of Clinical Sleep Medicine 2010 6 1 85 95
170. Li F., Calingasan N. Y., Yu F., Mauck W. M., Toidze M., Almeida C. G., Takahashi R. H., Carlson G. A., Beal M. F., Lin M. T., Gouras G. K., Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice Journal of Neurochemistry 2004 89 5 1308 1312 (Pubitemid 38715849)
171. Melov S., Adlard P. A., Morten K., Johnson F., Golden T. R., Hinerfeld D., Schilling B., Mavros C., Masters C. L., Volitakis I., Li Q. X., Laughton K., Hubbard A., Cherny R. A., Gibson B., Bush A. I., Mitochondrial oxidative stress causes hyperphosphorylation of tau PLoS One 2007 2 6, article no. e536
172. Massaad C. A., Pautler R. G., Klann E., Mitochondrial superoxide: a key player in Alzheimer's disease Aging 2009 1 9 758 761
173. Santos R. X., Correia S. C., Wang X., Perry G., Smith M. A., Moreira P. I., Zhu X., Alzheimer's disease: diverse aspects of mitochondrial malfunctioning International Journal of Clinical and Experimental Pathology 2010 3 6 570 581
174. Atlante A., Bobba A., Petragallo V. A., Marra E., Alzheimer's proteins, oxidative stress, and mitochondrial dysfunction interplay in a neuronal model of Alzheimer's disease International Journal of Alzheimer's Disease 2010 2010 11
175. Mller W. E., Eckert A., Kurz C., Eckert G. P., Leuner K., Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease-therapeutic aspects Molecular Neurobiology 2010 41 2-3 159 171
176. Manczak M., Mao P., Calkins M. J., Cornea A., Reddy A. P., Murphy M. P., Szeto H. H., Park B., Reddy P. H., Mitochondria-targeted antioxidants protect against amyloid- toxicity in Alzheimer's disease neurons Journal of Alzheimer's Disease 2010 20 supplement 2 S609 S631
177. Galindo M. F., Ikuta I., Zhu X., Casadesus G., Jordn J., Mitochondrial biology in Alzheimer's disease pathogenesis Journal of Neurochemistry 2010 114 4 933 945
178. Reddy P. H., Manczak M., Mao P., Calkins M. J., Reddy A. P., Shirendeb U., Amyloid- and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline Journal of Alzheimer's Disease 2010 20 supplement 2 S499 S512
179. Chen J. X., Yan S. S., Role of mitochondrial amyloid- in Alzheimer's disease Journal of Alzheimer's Disease 2010 20 supplement 2 S569 S578
180. Mancuso M., Orsucci D., LoGerfo A., Calsolaro V., Siciliano G., Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA Advances in experimental medicine and biology 2010 685 34 44
181. Cardinali D. P., Furio A. M., Brusco L. I., Clinical aspects of melatonin intervention in Alzheimer's disease progression Current Neuropharmacology 2010 8 3 218 227
182. Matsubara E., Bryant-Thomas T., Quinto J. P., Henry T. L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y. J., Smith M. A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G. L., Ghiso J., Williams C., Refolo L. M., Pappolla M. A., Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease Journal of Neurochemistry 2003 85 5 1101 1108 (Pubitemid 36613258)
183. Feng Z., Chang Y., Cheng Y., Zhang B. L., Qu Z. W., Qin C., Zhang J. T., Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease Journal of Pineal Research 2004 37 2 129 136 (Pubitemid 39120217)
184. Olcese J. M., Cao C., Mori T., Mamcarz M. B., Maxwell A., Runfeldt M. J., Wang LI., Zhang C., Lin X., Zhang G., Arendash G. W., Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease Journal of Pineal Research 2009 47 1 82 96
185. Jang MI. H., Jung S. B., Lee M. H., Kim C. J., Oh Y. T., Kang I., Kim J., Kim EE. H., Melatonin attenuates amyloid beta-induced apoptosis in mouse microglial BV2 cells Neuroscience Letters 2005 380 1-2 26 31 (Pubitemid 40602323)
186. Hung C. H. L., Ho Y. S., Chang R. C. C., Modulation of mitochondrial calcium as a pharmacological target for Alzheimer's disease Ageing Research Reviews 2010 9 4 447 456
187. Dong W., Huang F., Fan W., Cheng S., Chen Y., Zhang W., Shi H., He H., Differential effects of melatonin on amyloid- peptide 25-35-induced mitochondrial dysfunction in hippocampal neurons at different stages of culture Journal of Pineal Research 2010 48 2 117 125
188. Wang X., The antiapoptotic activity of melatonin in neurodegenerative diseases CNS Neuroscience and Therapeutics 2009 15 4 345 357
189. Quinn J., Kulhanek D., Nowlin J., Jones R., Pratic D., Rokach J., Stackman R., Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials Brain Research 2005 1037 1-2 209 213 (Pubitemid 40362399)
190. Gauthier S., Reisberg B., Zaudig M., Petersen R. C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J. L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M. C., Whitehouse P., Winblad B., Mild cognitive impairment Lancet 2006 367 9518 1262 1270
191. Jean-Louis G., Von Gizycki H., Zizi F., Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment Journal of Pineal Research 1998 25 3 177 183 (Pubitemid 28430598)
192. Peck J. S., LeGoff D. B., Ahmed I., Goebert D., Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study American Journal of Geriatric Psychiatry 2004 12 4 432 436 (Pubitemid 38878863)
193. Furio A. M., Brusco L. I., Cardinali D. P., Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study Journal of Pineal Research 2007 43 4 404 409 (Pubitemid 47512272)
194. Riemersma-van Der Lek R. F., Swaab D. F., Twisk J., Hol E. M., Hoogendijk W. J. G., Van Someren E. J. W., Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial Journal of the American Medical Association 2008 299 22 2642 2655 (Pubitemid 351831594)
195. Tnez I., Montilla P., Muoz M. D.C., Feijo M., Salcedo M., Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease Journal of Pineal Research 2004 37 4 252 256 (Pubitemid 39457046)
196. Oliveira J. M. A., Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum Journal of Neurochemistry 2010 114 1 1 12
197. Heiser V., Scherzinger E., Boeddrich A., Nordhoff E., Lurz R., Schugardt N., Lehrach H., Wanker E. E., Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6739 6744 (Pubitemid 30412784)
198. Wetterberg L., Iselius L., Lindsten J., Genetic regulation of melatonin excretion in urine. A preliminary report Clinical Genetics 1983 24 6 399 402 (Pubitemid 14202452)
199. Grof E., Grof P., Brown G. M., Investigations of melatonin secretion in man Progress in Neuro-Psychopharmacology and Biological Psychiatry 1985 9 5-6 609 612 (Pubitemid 16148268)
200. Bergiannaki J. D., Soldatos C. R., Paparrigopoulos T. J., Syrengelas M., Stefanis C. N., Low and high melatonin excretors among healthy individuals Journal of pineal research 1995 18 3 159 164
201. Griefahn B., Brde P., Remer T., Blaszkewicz M., Excretion of 6-hydroxymelatonin sulfate (6-OHMS) in siblings during childhood and adolescence Neuroendocrinology 2003 78 5 241 243 (Pubitemid 37505819)
202. Gaecki P., Szemraj J., Bartosz G., Biekiewicz M., Gaecka E., Florkowski A., Lewiski A., Karbownik-Lewiska M., Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder Journal of Pineal Research 2010 48 4 311 317